A concise review of HPLC, LC-MS and LC-MS/MS methods for determination of azithromycin in various biological matrices

Biomedical Chromatography

Volumn 27, Issue 10, 2013, Pages 1243-1258

  Sharma, Kuldeep ^a   Mullangi, Ramesh ^a  

^a JUBILANT BIOSYS LTD   (India)

Author keywords

Azithromycin; Bioanalytical methods; HPLC; LC MS MS; Review

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACID STABILITY; AGLYCONES; AZITHROMYCIN; BIOANALYTICAL METHODS; BIOLOGICAL MATRIXES; HPLC; LC-MS-MS; LC.MS/MS; MACROLIDES; STRUCTURAL MODIFICATIONS;

ANTIBIOTICS;

ACID; AZITHROMYCIN; ERYTHROMYCIN;

ARTICLE; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; RESPIRATORY TRACT INFECTION; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; SOFT TISSUE INFECTION;

EID: 84883558816     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2898     Document Type: Article

References (24)

1. Bahrami G and Mohammadi B. A new on-line, in-tube pre-column derivatization technique for high performance liquid chromatographic determination of azithromycin in human serum. Journal of Chromatography B 2006; 830: 355-358.
2. Bahrami G, Mirzaeei S and Kiani A. High performance liquid chromatographic determination of azithromycin in serum using fluorescence detection and its application in human pharmacokinetic studies. Journal of Chromatography B 2005; 820: 277-281.
3. Barrett B, Borek-Dohalsky V, Fejt P, Vaingatova S, Huclova J, Nemec B and Jelinek I. Validated HPLC-MS-MS method for determination of azithromycin in human plasma. Analytical and Bioanalytical Chemistry 2005; 383: 210-217.
4. Bright GM, Nagel AA, Bordner J, Desai KA, Dibrino JN, Nowakowska J, Vincent L, Watrous RM, Sciavolino FC, English AR, Retsema JA, Anderson MR, Brennan LA, Borovoy RJ, Cimochowski CR, Faiella JA, Girard AE, Girard D, Herbert C, Manousos M and Mason R. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives: a new class of macrolide antibiotics, the azalides. Journal of Antibiotics 1988; 41: 1029-1047.
5. Chen BM, Liang YZ, Chen X, Liu SG, Deng FL and Zhou P. Quantitative determination of azithromycin in human plasma by liquid chromatography-mass spectrometry and its application in a bioequivalence study. Journal of Pharmaceutical and Biomedical Analysis 2006; 42: 480-487.
6. Chen L, Qin F, Ma Y and Li F. Quantitative determination of azithromycin in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry and its application in a pharmacokinetic study. Journal of Chromatography B 2007; 855: 255-261.
7. Choemunng A and Na-Bangchang K. An alternative liquid chromatography mass spectrometric method for the determination of azithromycin in human plasma and its application to pharmacokinetic study of patients with malaria. The Southeast Asian Journal of Tropical Medicine and Public Health 2010; 41: 1048-1058.
8. Dunn CJ and Barradell LB. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 1996; 51: 483-505.
9. Ebrahimzadeh H, Yamini Y, Ara KM, Kamarei F and Khalighi-Sigaroodi F. Determination of azithromycin in biological samples by LLLME combined with LC. Chromatographia 2010; 72: 731-735.
10. Farmer S, Li Z and Hancock REW. Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic marcrolide azithromycin. The Journal of Antimicrobial Chemotherapy 1992; 29: 27-33.
11. Fouda HB and Schneider RP. Quantitative determination of antibiotic azithromycin in human serum by high-performance liquid chromatography (HPLC)-atmospheric pressure chemical ionization mass spectrometry: correlation with standard HPLC-electrochemical method. Therapeutic Drug Monitoring 1995; 17: 179-183.
12. Foulds G, Shepard RM and Johnson RB. The Journal of Antimicrobial Chemotherapy 1990; 25: 73-82.
13. Lalak NJ and Morris DL. Azithromycin clinical pharmacokinetics. Clinical Pharmacokinetics 1993; 25: 370-374.
14. Liu F, Xu Y, Huang J, Gao S and Guo Q. Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma. Biomedical Chromatography 2007; 21: 1272-1278.
15. Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R and Yerramilli A. Sensitive and selective liquid-chromatography-tandem mass spectrometry method for the quantification of azithromycin in human plasma. Analytica Chimica Acta 2005; 553: 1-8.
16. Peters DH, Friedel HA and McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs 1992; 576: 358-362.
17. Schentag JJ and Ballow CH. Tissue directed pharmacokinetics. American Journal of Medicine 1991; 91: 5S-11S.
18. Shen Y, Yin C, Su M and Tu J. Rapid, sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the quantitation of topically applied azithromycin in rabbit conjunctiva tissue. Journal of Pharmaceutical and Biomedical Analysis 2010; 52: 99-104.
19. Shepard RM and Falkner FC. Pharmacokinetics of azithromycin in rats and dogs. The Journal of Antimicrobial Chemotherapy 1990; 25: 49-60.
20. Torano JS and Guchelaar HJ. Quantitative determination of the macorlide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarobnylchloride and fluorescence detection. Journal of Chromatography B 1998; 720: 89-98.
21. Wilms E, Trumpie H, Veenendal W and Touw D. Quantitative determination of azithromycin in plasma, blood and isolated neutrophils by liquid chromatography using pre-column derivatization with 9-fluorenylmethyloxycarbonylchloride and fluorescence detection. Journal of Chromatography B 2005; 814: 37-42.
22. Yuzuak N, Ozden Y, Eren S and Toptan S. Analysis of azithromycin in human plasma by LC-MS/MS. Chromatographia 2007; 66: S115-S118.
23. Xu F, Zhang Z, Bian Z, Tian Y, Jiao H and Liu Y. Azithromycin quantitation in human plasma by high-performance liquid chromatography coupled to electrospray mass spectrometry: application to bioequivalence study. Journal of Chromatographic Science 2008; 46: 479-484.
24. Xue-Min Z, Jie L, Juan G, Quan-Shing Y and Wen-Yan W. Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics. Pharmazie 2007; 62: 255-257.